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Summary: A specific radioimmunoassay for 4-androstene-3,17-dione (androstenedione) based on rabbit antisera to
6j3-hydrpxy-4-androstene-3,17-dione^6-hemisuccinate-bovine serum albumin conjugate was developed. Cross reaction
by testosteröne was eliminated by additipn of experimentally established amounts of testosterone antiserum, which
cross reacted by only 0.004 with androstenedione. The method has been used fpr simultaneous determination of
androstenedione in both plasma and saliva of normal women under basal conditions and following dynamic tests.
The plasma levels in normal women averaged 3.6 ± 0.9 nmol/1 and cprrelated (r - 0.93) with those found in saliva
(0.353 ± 0.089 nmol/1).
Radioimmunoassay für Androstendion in Plasma und Speichel
Zusammenfassung: Für die Bestimmung von 4-Androsten-3,17rdion (Androstendion) wurde ein spezifischer Radio-
immunoassay ausgearbeitet. Antiserum gegen 64^Hydroxy^-mdrosten-3,17-dioh-6-hemisuccinat-Rindsem
wurde an Kaninchen gewonnen. Die Kreuzreaktipn mit Testosteron wurde durch eine Zugabe von Antiserum gegen
Testpsterpn unterdrückt. Dieses Antiseram ergab eine nur 0.004 Kreuzreaktion mit Androstendion; die benötigte
Menge wurde experimentell ermittelt. Die Methode wurde zur Androstendionbestimmung in Blutplasma und Spei-
chel bei normalen Frauen sowohl unter basalen Bedingungen als auch nach Provokations- und Hemmtesten verwen-
det. Die Mittelwerte der Androsteiidionkonzentratioyi in Blutplasma der Frauen lagen bei 3.6 ± 0.9 nmol/1 und im
Speichel bei 0.353 + 0.089 nmol/1 mit einem Korrelationskoeffizienten von r = 0.93.
Iiitrodüction ^ ̂  pertinent problem with these methods remains
Andf ostenedione is a precursor of both testosterone and the interference of cross reacting testosterone. According
oestrogens in testes and ovaries, the gonads being also ' to Pratt et al. (8), this effeet can be reduced considerably
claimed äs a mäjor source of the circuläting hormone, at by additiori to the System of a certain amount of anti-
least in women (1). Its increase in early stages of puberty serum against the competitor. We have tested this proce-
preceeds the appearance of higher testosterone levels dure, using testosterone antiserum, cross reacting by
(2) and it therefpre inay be an important indicator of only 0:004 with androstenedione (9) for the radio-
sexual maturation. immunoassay of the latter in plasma and saliva. Antisera
Published radioimmunoassays use antibodies raised raised against androstenedione-6|3-hemisuccinate-bovine
against androstenedione derivatives attached to a carrier serum albumin and l -hemisuccinate-bovine serum
protein through positions 3 (3,4), 6 (5), 11 (6) or 19 albumin were compared.
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Materials and Methods
Stcroids
[1,2,6,7-3H)Androstenedione and [l,2,6,7-3H]testosterone of
specific radioactivities 3.18 TBq/mmol (86 Ci/mmol) and
3.21 TBq/mmol (87 Ci/mmol), respectively, from Radiochemical
Centre, Amersham (England) were purified by paper chromato-
graphy in the System cyclohexane-toluene-methanol-water (9 +
l + 8 + 2 by volume). This System was also used in the assay for
Separation of androstenedione from testosterone.
ll]3-Hydroxy-4-androstene-3,17-dione was prepared by alkali
induced cleavage of the side chain of cortisol (10). Other non-
radioactive steroids were purchased from Steraloids (Pawling,
USA).
Synthesis of immunogens
The starting compounds, 6 -hydroxy-4^androstene-3,17-dione
and llo:-hydroxy-4-androstene-3,17-dione were prepared by
oxidation of the dihydroxyacetone side chain of 60,17a,21-
trihydroxy-4-pregnene-3,20-dione and llo£,17a,21-trihydroxy-
4-pregnene-3,20-dione (60-hydroxycortisol and epicortisol,
respectively) with sodium bismuthate (11). The identity of the
products was confirmed by thin layer chromatography with
small amounts of authentic steroids from Steraloids. The resulting
6/3- and lla-hydroxyandrostenediones were acylated with
succinic anhydride in dry pyridine (12), and the hemisuccinates
obtained were preparatively purified on thin layer silica gel
(Merck F-254, Darmstadt, FRG) in ethyl acetate. The mixed
anhydride method (13) was used for coupling these compounds
to bovine serum albumin. The steroid/protein molar rati s
were 21 and 6 for the 6 - and 11 α-derivative, respectively.
Preparation of antisera
5 Month-old rabbits (3 animals for each conjugate) were im-
munized with the above antigens in complete Freund 's adjuvant-
saline mixture (l + l by volume) by intradermal injections
(l mg in l ml) at three-weeks intervals. The antiserum against
testosterone-3-carboxymethyloxime-bovine serum albumin was
raised previously (9).
Sampling of plasma and saliva
Blood was removed by venipuncture at 7 a. m. in 15 normal
premenopausal women in the follicular phase. At the same time
saliva (at least 2 ml) was collected and stored frozeri at =· 20 °C.
FoUowing thawing practically no emulsion occuxred. Cortico-
tropin Stimulation in 6 normal women s performed by
Synacthen® infusion (0.25 mg in 400 ml pf saline, Ciba, Basle,
Switzerland) at 7 a. m., repeated on two successive days. Both
blood and saliva were collected 8 hours after beginning of the
infusion on each day. Dexamethasone suppression using
Dexamethazon-Spofa (Czechoslovakia) was performed in 12
women. They were given 4 X 0.5 mg for the first two days
and 4 X 2 mg during the third and fourth day. Blood and saliva
were sampled at 7 a. m. on the 3rd and 5th day of the test.
Human chorionic gonadotropin Stimulation was performed in
12 normal women by two i. m. injections of 3000 I.U. of
Praedyn-Spofa (Czechoslovakia), under simultaneous supression
with dexamethasone (8 mg for two days). Blood and saliva
were collected on the morning of the second and third day of
this test. The metyrapone test consisted of 6 oral doses of
Metopirone (Ciba, Basle, Switzerland, 0.75 g every 4 h) for 24 h.
Blood and saliva were collected 24 and 48 hours after the Start
of drug administration.
Sample preparation
Plasma (400 μΐ) was extracted with diethyl ether (4 ml) on the
vortex mixer for 2 min. Aliquots of the extract (500 μΐ, corre-
sponding to 50 μΐ of plasma) were transferred into test tubes and
evaporated to dryness. Saliva (l ml) was extracted in the same
way with 5 ml of ether and l ml portions of the extract (equi-
valent to 200 μΐ of saliva) were taken for radioimmunoassay.
Radioimmuno assay
To the dry residues of extracts or to Standard Solutions pf
androstenedione (0, 6.25-400 pg in 100 μΐ of buffer), the
buffered Solutions (100 μΐ each) of the radioligand (167 Bq, i.e.
10000 min"1) and antisera mixture (anti-androstenedione-60·
hemisuccinate-bovine serum albumin, working dilution 1:2000 +
anti-testosterone-3-carboxymethyloxime-bovine serum albumin,
working dilution 1:8000) were added successively, and the
volume adjusted to 500 μΐ with buffer (50 mmol/1 Na,K-phos-
phate, pH 7.4, containing 0.078 mol/1 NaQ,fl5.4 mmol/l sodium
azide and l g/l bovine ser m albumin). The samples for deter-
mination of nonspecific binding and for the total radioactivity
were processed in parallel. After iriixing (vortex mixer), the
samples were incubated at 37 °Cfor 30min and then in an ice
bath for l h, Bound and free fractions were separated by adding
dextran-coated eharco l (500 μΐ, 0.25 g/l Dextran T-7Q and
2.5 g/l Norit A). The mixture was briefly vortexed, left to stand
at 0 °C for 20 min and centrifuged. The radioactivity iri 500 μΐ
of the supernatant was then measured.
Miscellaneous
All chemicals were of analytical grade, diethyl ether was freed of
peroxides and freshly distiiled. Radioactivity was nie sured on
Packard-Tricarb (USA) liquid scintillation spectrometer. The
scintiUation fluid consisted of 4 g PP , 50 mg POP P and 20 ml
of methanol in l liter of toluene. The log-logit plot was ip tiriely
used for calculation of radioimmunoassay results.
Results
Characterization of the antisera
The rabbits were immunized with the bove immunogens
till at least one rabbit in each group responded with an
antiserum titer of 10"4. Tbi_s was achieved after 7 and 9
months, using the 6/3- and lla-immunpgen, respectively.
The specifity of both androstenedione antisera and of
the testosterone antiserum added1 t the assay System, in
terms of cross reactions with 16 hormonal steroids, are
listed in table 1. They were calculated from amounts pf
competing material causing 50% displacement of the
radioligand according toPratt (method A) (14). For
radioimmunoassay purposes the 6j3-antiser m was chosen,
since it exhibited negligible cross-reaction with 110-
hydroxy^-androstene-'SjlT^dione and showed practically
no binding of cortisol; the ciossrreaction of Cortisol with
l l(*-antiserum was top high tp be ignpred, in view of the
cortisol concentrations in plasma and saliva.
Estimation of the optimal concentration
of testosterone antiserum
The amount of testosterone antiserum to be added to
the assay System was estirn ted experimentally according
toPratt (8), s the antiserum dilution at which the cross-
reaction of the chosen amount of the competitpr
(0.345 prnol i.e. 100 pg, corresppnding to mid-values in
analyzed samples) is less th n 0.1. As showri in table 2,
the working dilution l: 8000 fulfils this requirement.
Urider these conditions the calibr tion curves oif andro-
stenedione in the presence or absence of testosterone did
not differ significantly. Using log-logit transformation,
the following typical equati ns were obtained; without
cpnjpetitor y = 3.86 - l.01 x, with competitor and testo-
sterone.aritiserum y = 4.10 - 1.16 χ (where χ is the
logarithm of androstenedione concerinration),
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Tab. 1. GOSS reactions of various steroids with rabbit antisera against 6^hydroxy-4-androstene-3,17-dione-6-hemisuccinate-(6/3-deriva-
tive), lla-hydroxy-4-androstene-3,17-dione-ll-hemisuccinate-(l -derivative) and testosterone-3-carboxymethyloxime-(testo-
sterone derivative) bovine serum albumin conjugates. [3H]androstenedione and [3H)testosterone were used äs radioligands.
Steroid
4- Androstene^3 , 1 7-dione
5 - An drostane-3,1 7-dione

































































Tab. 2. The effect of various dilutions of testosterone antiserum
added to the System containing 0.345 pmol (100 pg) of
testosterone and antiserum against 60-hydroxy-4-andro-
stene-3,17-dione-6-hemisuccinate^bovine serum albumin
(working dilution l :2000). The cross reactivity of andro-
stenedione with the above antiserum was 0.0042.
Dilution of testosterone antiserum Relative binding of
[3 H]androstenedionea)







a) Related to binding of the radioligand to androstenedione
antiserum alone without addition of competing testosterone.
Reliability criteria of the method
Precision
Two plasma samples containing 3.4 and 6.2 nmol/1 of
androstenedione were assayed 20 times in pne series
and within 10 separate series. The coefficients of varia^
tion were 5.82 and 4.93% (intraassay) and 11.9 and
11.3% (interassay), respectively.
Accuracy
The average recoveries (n - 10) of 1.38 and 2.76 pmol
• (400 and 8ÖQ pg) pf androstenedione added to 400 jul
of plasma containing 3.47 nmol/1 of endogerious hor-
mpne were 0.978 and 1.035, respectively.
10 Plasma samples from healthy women with andro-
stenedione conceritrations ranging from 1.58 to
12.9 nmol/I (i.e. including samples from dynamic tests)
were further assayed by three different procedures äs
follows:
1) The method described,
2) the same method but without addition of testosterone
antiserum and
3) the above radioimmunoassay without addition of
testosterone antiserum, after paper chromatography of
the extracts.*
In the latter case the results were corrected on the basis
of the recovery of an added tracer (16.7 Bq of [3H]andro-
stenedione per tube).





Using t-test for paired values, no significant differences
were found between the results of the described method
and those from the method with Chromatographie Separa-
tion pf crpss reacting testosterone. On the other hand,
significäntly higher eoncentrations (P < 0.01) were
measured when no testosterpne antiserum was added to
the assay System.
Semitivity
The least detectable amount of androstenedione, cal-
culated from repeated (n = 10) analysis of charcoal
treated steroid-free plasma was 3 pg (0.0105 pmol). The
average 50% intercept of the calibration curve was
32 pg (0.11 pmol) per tube.
Androstenedione eoncentrations in plasma
and saliva
The basal concentrations of androstenedione in 15 nor-
mal premenppausal women in plasma and saliva äs well
äs following four dynamic tests are summarized in
table 3.
The plasma levels correlated well with those found in
saliva within the whole region of values obtained. Regres-
sion analysis of the results of androstenedione concentra-
tion in plasma (y) and saliva (x) showed the equation
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y = 0.17x - 0.22 with the respective correlation
r = 0.931.
Discussion
Though avoiding a Chromatographie step, the method
described is specific enough for routine measurement of
androstenedione in biological fluids including saliva.
The interference of testosterone is diminished by addi-
tion of an experimentally established amount of specific
testosterone antiserum. Using androstenedione anti-
serum raised by an immunogen prepared through the
60-position on the steroid molecule, the effect on the
assay of 11/3-hydroxyandrostenedione, an important
steroid of exclusively adrenal origin (4,12) may be
neglected. Strongly cross reacting isomeric androstane-
diones are known äs urine metabolites and occur in
plasma only in negligible quantities. 17-Oxosteroids
are present in plasma äs sulphates and are practically not
extracted with most of organic solvent? including diethyl
ether.
The reliability criteria are within the litnits usüally ob-
tained for radioimmunoassay. The basal levels of plasma
androstenedione, äs well äs values obtained following
dynamic tests, agree well with earlier reported data (l,
3,4, 5,7). To our knowledge, our results are the first
concerning the radioimmunologicaljestimatiori of
androstenedion$ in saliva. Assay of steroids in saliva
rather than in plasma is no doubt advantagenous,
especially in children, aiid also in the dynamic test,
with serial collection of samples. As demonstrated, the
concentrations of androstenedione in saliva are äbout .
one order of rnagnitude less than those measured in
plasma. The values from dynamic tests follow the same
pattem äs in plasma.
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